-
Mashup Score: 0
The year 2012 is often regarded as the beginning of the deep learning revolution. That year, Alexnet, the deep learning model proposed in the research paper Imagenet Classification with Deep Convolutional Neural Network by Alex Krizhevs ky and his colleagues, won the large-scale visual recognition challenge ImageNet — completely dominating over other machine learning competitors. Scientists at Google’s mysterious X lab built a neural network of 16,000 computer processors with one billion connections,
Source: www.biopharmatrend.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2Pharma’s Data Dilemma: How Machine-Learning Tools Hold the Key to Unlocking Novel Insights - 3 year(s) ago
Covid-19 is still having a devastating effect on many countries and economies worldwide and has brought to light the impact of diseases that affect some people in worse ways than others. With SARS-CoV-2, ethnicity, gender, age, and underlying health conditions all play a part in disease severity and mortality, but there is mounting evidence to…
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Tech Providers or Biotechs: The Quest to Find an Optimal Business Model Continues for AI Drug Discovery Companies… - 3 year(s) ago
The AI drug discovery industry has already gathered momentum with AI start-ups having signed more than 200 deals with 50+ pharma companies over the last few years, and these are just the disclosed deals. Few top companies like InSilico Medicine and Cyclica claim to have over 100 collaborations each with Academia and Industries. With billions of…
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Did you know? According to a study from Accenture, 60% of patients would prefer access to care via telehealth technology using digital communication tools than walking to a doctor’s office. The verdict is mounting that digital and telehealth communication is here to stay with us. Telehealth adoption has exploded since the onset…
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0The AI Productivity Game in Pharma - 3 year(s) ago
The pharmaceutical business is one of the riskiest industries to venture into. Drug discovery is an artisanal process where a carefully designed drug takes about 10 years and approximately 2.5 billion dollars to be approved and launched into the market. The complexity of biological systems places the odds at a ridiculous failure rate of 90%. In…
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2Pharmaceutical Artificial Intelligence in 2020: The Sector is Heating Up For Investments - 3 year(s) ago
Table of Contents: Introduction The abundance of venture capital, major funding rounds New AI-driven biotech startups founded in 2020 Notable AI-focused collaborations involving “big pharma” players AI adoption by the contract research organizations (CROs) AI-designed drug candidates in clinical trials The…
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 17 Notable AI Companies in Clinical Research to Watch in 2020 - 4 year(s) agoSource: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare - 4 year(s) ago
This is our interview with Dr. Christian Guttmann, VP and Head of Global AI & Data at TietoEVRY, and Executive Director of the Nordic AI Institute, discussing a new regulatory framework for the widespread application of Artificial Intelligence in the European ecosystem, proposed by EU.
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1BPT Editor Tool | BiopharmaTrend - 4 year(s) ago
An interactive online report powered by our database and sophisticated data mining engine
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1The Increasing Potential of Virtual Reality in Drug Design - 4 year(s) ago
Virtual reality is increasingly applied in the drug discovery, by startups and larger organizations.
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet
It’s Been a Decade of AI in the Drug Discovery Race. What’s Next? https://t.co/JFyesFGLrm https://t.co/YgXz8KQFSX